article Open AccessTop 1% cited
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
The Lancet Oncology · 2014 · Vol. 15(12) · pp. 1303–1310
Mila Donker✉(The Netherlands Cancer Institute)Geertjan van Tienhoven(Academic Medical Center)Marieke E. Straver(The Netherlands Cancer Institute)Philip Meijnen(The Netherlands Cancer Institute)Cornelis J.�H. van de VeldeRobert E. Mansel(Cardiff University)Luigi Cataliotti(Azienda Ospedaliero-Universitaria Careggi)A. Helen Westenberg(Radiotherapie Groep)Jean H. G. Klinkenbijl(Rijnstate Hospital)Lorenzo Orzalesi(Azienda Ospedaliero-Universitaria Careggi)Willem H. Bouma(Gelre Hospitals)H.C.J. van der Mijle(Ziekenhuis Nij Smellinghe)Grard A. P. Nieuwenhuijzen(Catharina Ziekenhuis)Sanne C. Veltkamp(Ziekenhuis Amstelland)Leen Slaets(European Organisation for Research and Treatment of Cancer)N. Duez(European Organisation for Research and Treatment of Cancer)Peter W. de Graaf(Reinier de Graaf Hospital)Thijs van Dalen(Utrecht University)Andreas Marinelli(Medisch Centrum Haaglanden)Herman Rijna(Spaarne Gasthuis)Marko Snoj(Institute of Oncology Ljubljana)Nigel Bundred(University of Manchester)J. W. S. Merkus(Haga Hospital)Yazid Belkacémi(Centre Oscar Lambret)Patrick Petignat(University Hospital of Geneva)Dominic A.X. Schinagl(Radboud University Nijmegen)Corneel Coens(European Organisation for Research and Treatment of Cancer)Carlo Messina(European Organisation for Research and Treatment of Cancer)Jan Bogaerts(European Organisation for Research and Treatment of Cancer)Emiel J. Rutgers(The Netherlands Cancer Institute)
Breast Cancer Treatment StudiesBreast Implant and ReconstructionBreast Lesions and CarcinomasMedicineAxillaBreast cancerAxillary Lymph Node DissectionRadiation therapySentinel nodeSurgerySentinel lymph nodeLymph nodeClinical endpoint
MeSH terms
AxillaBreast NeoplasmsEuropeFemaleHumansLymph NodesLymphatic MetastasisMiddle AgedNeoplasm Recurrence, LocalDisease-Free SurvivalSentinel Lymph Node Biopsy
Funding
- National Cancer Institute
Citations
1,796
FWCI
41.06
field-weighted impact
References
28
Percentile
100%
vs. same field & year
Citations per year
Cited by
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2019 · 2,185 citations
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2010 · 2,860 citations
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2015 · 1,618 citations
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
Annals of Oncology · 2015 · 1,820 citations
Breast Cancer Treatment
JAMA · 2019 · 4,716 citations
References
Interpreting the significance of changes in health-related quality-of-life scores.
Journal of Clinical Oncology · 1998 · 2,890 citations
Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer
Breast Cancer Research and Treatment · 2005 · 493 citations
Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer
Annals of Surgery · 1994 · 2,898 citations
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases
Annals of Surgery · 2010 · 1,242 citations
Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial
JNCI Journal of the National Cancer Institute · 2006 · 1,660 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.